CLINICAL_TRIALS
trial_result
· 2024-04-08
Clinical Trial Update: Efficacy and Safety of Tolebrutinib (SAR442168) Tablets in Adult Participants With Generalized Myasthenia Gravis [Phase 3]
Summary
Phase 3 trial of tolebrutinib for generalized myasthenia gravis was terminated, but efficacy and safety results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Myasthenia Gravis | Phase 3 | Status: TERMINATED | Results posted: 2024-04-08